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Materials and Procedures 
All reagents were purchased from commercial suppliers and used as received 
unless stated otherwise. Aβ1-40 peptide was purchased from AnaSpec (Fremont, CA, 
USA). The amino acid sequence for the Aβ1-40 peptide is 
DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV. Myricetin was 
purchased from AvaChem Scientific (San Antonio, TX, USA) and was used without 
further purification. Optical spectra were collected on an Agilent 8453 UV-visible 
spectrophotometer. Transmission electron microscopy (TEM) images were taken using 
a Philips CM-100 transmission electron microscope. A SpectraMax M5 microplate 
reader (Molecular Devices) was used for measurements of absorbance for the cell 
viability assay. 
 
UV-vis Studies. To understand metal binding properties of myricetin, optical 
spectra were obtained for the solutions of myricetin (25 µM in 20 mM HEPES (2-[4-(2-
hydroxyethyl)piperazin-1-yl]ethanesulfonic acid), pH 7.4, 150 mM NaCl) and myricetin 
incubated with CuCl2 or ZnCl2 (25 µM) for 5 min (room temperature), respectively 
(Figure S1). To verify if metal chelation occurs by myricetin in the presence of Aβ, 
optical studies were carried out on samples of Aβ (25 µM) and CuCl2 or ZnCl2 (25 µM, 2 
min incubation, room temperature) in the absence and presence of myricetin (25 µM, 
incubation for 5 min, Figure S1). 
 
Amyloid-β (Aβ) Peptide Experiments. Aβ samples were prepared according to 
the previously reported procedures.[1-4] All solutions were treated thoroughly with 
Chelex prior to use (Sigma Aldrich) to remove trace metal ion contamination. The Aβ 
peptide was dissolved in 1% NH4OH (w/v, aq), aliquoted to 10 samples, lyophilized, 
and stored at –80 °C. Stock solutions of Aβ were prepared prior to the experiments by 
redissolving the lyophilized Aβ with 1% NH4OH (w/v, aq, 10 µL) and diluting with 
ddH2O. Solutions for inhibition and disaggregation studies were prepared in a buffered 
solution (20 µM HEPES, pH 7.4, 150 µM NaCl). For the inhibition studies, fresh Aβ (25 
µM) was incubated with either CuCl2 or ZnCl2 (25 µM) for 2 min at room temperature 
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followed by addition of myricetin (50 µM). The solutions were incubated for 24 h at 37 
°C with constant agitation. For the disaggregation studies, metal-Aβ aggregates were 
prepared by treating fresh Aβ (25 µM) with CuCl2 or ZnCl2 (25 µM) and incubating for 24 
h at 37 °C with constant agitation. Afterwards, myricetin (50 µM) was added and the 
resulting solutions were incubated for 4 h at 37 °C with continuous agitation. Metal-free 
Aβ samples were prepared at the same condition in the absence of metal chloride salts. 
The degree of Aβ aggregation and the morphology of Aβ species samples from the 
inhibition and disaggregation studies were analyzed by native gel electrophoresis using 
Western blotting with an anti-Aβ antibody 6E10 (Covance, Princeton, NJ, USA) and by 
TEM.[1-3] 
 
Native Gel Electrophoresis and Western Blotting. The reactions described 
above (Aβ Peptide Experiments) and in Figures 1 – 3 were visualized by native gel 
electrophoresis followed by Western blotting using an anti-Aβ antibody (6E10).[2-4] Each 
sample (25 µM Aβ, 10 µL) was separated on a 10 – 20% gradient Tris-tricine gel 
(Invitrogen). The gel was transferred onto a nitrocellulose membrane, blocked with 
bovine serum albumin (BSA, 3% w/v, Sigma) in Tris-buffered saline (TBS, Fisher) 
containing 0.1% Tween-20 (TBS-T, Sigma) for 3 h at room temperature, and incubated 
with an anti-Aβ antibody 6E10 (1:2,000) in 2% BSA in TBS-T for 3 h at room 
temperature. The membrane was probed with the horseradish peroxidase-conjugated 
goat anti-mouse antibody (1:10,000; Cayman Chemical, Ann Arbor, MI, USA) in 2% 
BSA in TBS-T for 1 h at room temperature. The Thermo Scientific Supersignal West Pico 
Chemiluminescent Substrate was used to visualize protein bands.  
 
Transmission Electron Microscopy (TEM). Samples for TEM were prepared by 
following the previously reported method.[1-4] Glow-discharged grids (Formar/Carbon 
300-mesh, Electron Microscopy Sciences) were treated with samples from the inhibition 
or disaggregation experiments (5 µL) for 2 min at room temperature. Excess sample 
solution was removed using filter paper followed by washing three times with ddH2O. 
Each grid was incubated with 1% uranyl acetate (ddH2O, 5 µL) for 1 min. Extra uranyl 
acetate was removed and the grids were dried for 15 min at room temperature. Images 
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from each sample were taken by a Philips CM-100 transmission electron microscope (80 
kV, 25,000x magnification). 
 
Cell Viability (MTT Assay). Human neuroblastoma SK-N-BE(2)-M17 (M17) cells 
were purchased from the American Type Culture Collection. The M17 cells were 
maintained in 1:1 Minimum Essential Media (MEM, GIBCO) and Ham’s F12K Kaighn’s 
Modification Media (F12K, Cellgro), containing 10% (v/v) fetal bovine serum (FBS, 
Atlanta Biologicals), 100 U/mL penicillin, and 100 mg/mL streptomycin (Invitrogen). 
The cells were grown at 37 °C in a humidified atmosphere of 5% CO2. Cell viability was 
measured using the MTT (MTT = 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide, Sigma Aldrich) assay.[2,3] Cells were seeded in a 96 well plate (1,600 cells in 100 
µL per well) and treated with Aβ (10 µM) and CuCl2 or ZnCl2 (10 µM) immediately 
followed by myricetin (20 µM, final 1% DMSO (v/v)). After 24 h incubation of the cells 
at 37 °C, the cells were treated with 25 µL MTT (5 mg/mL in phosphate buffered saline 
(PBS), pH 7.4) for 4 h at 37 °C. The cells were lysed in a buffered solution containing 
N,N-dimethylformamide (pH 4.5, 50% (v/v, aq)) and sodium dodecyl sulfate (SDS, 20% 
(w/v)) overnight at room temperature in the dark. The absorbance (A600) was measured 
using a microplate reader and cell viability (%) was calculated relative to that of cells 
containing only 1% DMSO (v/v, control cells).  
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Figure S1. UV-vis studies showing the interaction of myricetin with metal ions in the 
presence of Aβ. A) The spectra of myricetin in the absence (blue) and presence (red) of 
CuCl2 or ZnCl2 following 5 min incubation. B) The spectra of the samples containing 
Aβ, metal ions, and/or myricetin. To Aβ (black), CuCl2 or ZnCl2 was added 
immediately and incubated for 2 min (green). The solution containing Aβ and CuCl2 or 
ZnCl2 was treated with myricetin for 5 min (red). The spectrum of metal-free Aβ and 
myricetin is shown in blue. Experimental conditions: [Aβ] = 25 µM, [CuCl2 or ZnCl2] = 
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